RecruitingNot ApplicableNCT06880016

Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies


Sponsor

Konya City Hospital

Enrollment

68 participants

Start Date

Jul 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the relationship between the method of surfactant administration and improvements in serial lung ultrasound findings in preterm infants requiring surfactant therapy.


Eligibility

Min Age: 1 DayMax Age: 5 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Evaluation of serial lung ultrasound data after ENSURE surfactant treatments and Evaluation of serial lung ultrasound data after LISA surfactant treatments for people with newborn complication and respiratory distress syndrome, newborn. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Day to 5 Days.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTEvaluation of serial lung ultrasound data after ENSURE surfactant treatments

Intubating the infant, administering intratracheal surfactant, and then extubating them back to nasal respiratory support (ENSURE method)

DIAGNOSTIC_TESTEvaluation of serial lung ultrasound data after LISA surfactant treatments

Delivering surfactant via a thin catheter (5F) directly into the trachea while the infant remains on existing nasal respiratory support, without disconnecting them from it (LISA method)


Locations(1)

Melek Buyukeren

Konya, Karatay, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06880016


Related Trials